Arid

浏览/检索结果: 共3条,第1-3条 帮助

已选(0)清除 条数/页:   排序方式:
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial 期刊论文
发表期刊: JOURNAL OF CROHNS & COLITIS. 出版年: 2024, 卷号: 18, 期号: 6, 页码: 885-894
作者:  Yarur, Andres J.;  Chiorean, Michael, V;  Panes, Julian;  Jairath, Vipul;  Zhang, Jinkun;  Rabbat, Christopher J.;  Sandborn, William J.;  Vermeire, Severine;  Peyrin-Biroulet, Laurent
收藏  |  浏览/下载:15/0  |  提交时间:2024/10/04
Etrasimod  ulcerative colitis  S1P receptor modulator  mucosal healing  endoscopic improvement-histologic remission  
FECAL CALPROTECTIN AND C-REACTIVE PROTEIN LEVELS ARE CORRELATED WITH LONG TERM CLINICAL AND ENDOSCOPIC OUTCOMES: ANALYSIS OF THE OASIS OPEN LABEL EXTENSION TRIAL OF ETRASIMOD FOR ULCERATIVE COLITIS 期刊论文
发表期刊: GASTROENTEROLOGY. 出版年: 2020, 卷号: 158, 期号: 6, 页码: S704-S705
作者:  Yarur, Andres J.;  Chiorean, Michael V.;  Zhang, Jinkun;  Reinisch, Walter;  Vermeire, Severine;  Panes, Julian;  Peyrin-Biroulet, Laurent;  Sands, Bruce E.;  Cabell, Chris;  Naik, Snehal U.;  Sandborn, William J.
收藏  |  浏览/下载:11/0  |  提交时间:2020/08/14
FECAL CALPROTECTIN AND C-REACTIVE PROTEIN LEVELS ARE CORRELATED WITH LONG TERM CLINICAL AND ENDOSCOPIC OUTCOMES: ANALYSIS OF THE OASIS OPEN LABEL EXTENSION TRIAL OF ETRASIMOD FOR ULCERATIVE COLITIS 会议论文
会议名称: Crohn's and Colitis Congress. 会议地点: Austin, TX. 会议日期: JAN 23-25, 2020
作者:  Yarur, Andres J.;  Chiorean, Michael V.;  Zhang, Jinkun;  Reinisch, Walter;  Vermeire, Severine;  Panes, Julian;  Peyrin-Biroulet, Laurent;  Sands, Bruce E.;  Cabell, Chris;  Naik, Snehal U.;  Sandborn, William J.
收藏  |  浏览/下载:9/0  |  提交时间:2021/01/08